Recent advances in γδ T cell biology: New ligands, new functions, and new translational perspectives

1. Verfasser: Dieter Kabelitz , [VerfasserIn]
Julie Dechanet-Merville , [VerfasserIn]
Umfang/Format: 1 online resource (269 pages).
Schriftenreihe: Frontiers Research Topics
Schlagworte:
Online Zugang: DOAB: download the publication
DOAB: description of the publication
LEADER 01858namaa2200481ui 4500
001 003027346
005 20221228153921.0
003 DE-2553
006 m o d
007 cr|mn|---annan
008 20210212s2016 xx |||||o ||| 0|eng d
020 |a 978-2-88919-784-2 
020 |a 9782889197842 
040 |a oapen  |c oapen  |b eng  |d DE-2553  |e rda 
024 7 |a 10.3389/978-2-88919-784-2  |c doi 
041 0 |a eng 
042 |a dc 
100 1 |a Dieter Kabelitz  |e author 
264 |b Frontiers Media SA,  |c 2016. 
700 1 |a Julie Dechanet-Merville  |e author 
245 1 0 |a Recent advances in γδ T cell biology: New ligands, new functions, and new translational perspectives 
300 |a 1 online resource (269 pages). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers Research Topics 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
653 |a Infection 
653 |a Butyrophilin 3A1 
653 |a Tumor-infiltrating lymphocytes 
653 |a cancer immunotherapy 
653 |a IL-17 
653 |a Pyrophosphates 
856 4 0 |a www.oapen.org  |u http://journal.frontiersin.org/researchtopic/2041/recent-advances-in-t-cell-biology-new-ligands-new-functions-translational-perspective  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/57758  |7 0  |z DOAB: description of the publication 
590 |a Online publication 
590 |a ebookoa1222 
590 |a doab 
942 |2 z  |c EB 
999 |c 3027346  |d 1431101 
952 |0 0  |1 0  |2 z  |4 0  |6 ONLINE  |7 1  |9 972985  |R 2022-12-28 14:39:21  |a DAIG  |b DAIG  |l 0  |o Online  |r 2022-12-28  |y EB